Pembrolizumab, 1 mg

Pembrolizumab is supplied with defined handling requirements for laboratory use. It is an immunoglobulin G4 monoclonal antibody, with a molecular formula of C266H383N465O833S6 and a molecular weight of approximately 149,265 g/mol. This compound belongs to the IgG class of proteins and selectively binds to programmed death-1 (PD-1) and its ligands, PD-L1 and PD-L2, inhibiting their interaction. Pembrolizumab is a key component in cancer treatment, particularly for melanoma, non-small cell lung cancer, and head and neck squamous cell carcinoma. It is supplied at a concentration of 1 mg per vial, making it suitable for precise dosing in research settings.

• CAS Number: 1374853-91-4